A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancer.
about
Amrubicin for relapsed small-cell lung cancer: a systematic review and meta-analysis of 803 patientsEfficacy and safety of amrubicin hydrochloride for treatment of relapsed small cell lung cancer.A phase II study of amrubicin as a third-line or fourth-line chemotherapy for patients with non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0901Phase I dose escalation study of amrubicin plus paclitaxel in previously treated advanced non-small cell lung cancer.Correlation between the efficacy of amrubicin and the previous chemotherapy regimen for relapsed small cell lung cancer.Review of the management of relapsed small-cell lung cancer with amrubicin hydrochloride.Partial Response in an RRx-001-Primed Patient with Refractory Small-Cell Lung Cancer after a Third Introduction of Platinum Doublets.The role of second-line chemotherapy in small cell lung cancer: a retrospective analysisRelapsed small cell lung cancer: treatment options and latest developments.Second-line therapy for small-cell lung cancer.Amrubicin: potential in combination with cisplatin or carboplatin to treat small-cell lung cancer.Over-expression of MDR1 in amrubicinol-resistant lung cancer cells.Interstitial lung disease associated with amrubicin chemotherapy in patients with lung cancer: a single institutional study.A retrospective study of amrubicin monotherapy for the treatment of relapsed small cell lung cancer in elderly patients.[Advances on treatment of small cell lung cancer with amrubicin].Efficacy and safety of nanoparticle albumin-bound paclitaxel monotherapy as second-line therapy of cytotoxic anticancer drugs in patients with advanced non-small cell lung cancer.Efficacy and safety of amrubicin-based regimen used as first-line for extensive-disease small-cell lung cancer: A meta-analysis of randomized controlled trials.Risk factors for predicting severe neutropenia induced by amrubicin in patients with advanced lung cancer.[Advances on treatment of limited-disease small cell lung cancer].Amrubicin monotherapy for elderly patients with relapsed extensive-disease small-cell lung cancer: A retrospective study
P2860
Q28072672-CCBA907B-A678-44E0-BC53-C386C4D125F7Q33393427-DE4DD8C4-97C4-4A3B-BEB4-A71D25969DB2Q33406103-318D71D2-B71F-4E03-99C7-5118BAE3763AQ33425130-BF8D6FE0-DE79-45E8-B82D-0AA86C729485Q33599044-0319FAC7-2CA2-4F4F-AA3E-3365C22D4307Q34789076-5DDBB4C6-10DE-42B4-8842-ED0C4982491DQ37045774-2E671A98-91D1-4EC1-B8F7-98E462E3453CQ37255073-3448BFD5-E3A2-4F69-82AE-260AA508C33DQ37598178-75C50A11-2F49-4B45-904B-BF4FCE016C2BQ37866795-4F874412-AAE9-480E-BF59-64471EFE0F1EQ38129050-C465D3CB-0640-4338-A711-65C86391404EQ39624458-49E5D85D-261A-4A8A-9F3D-DC63E2F68B1CQ39780381-FD1EDB47-9792-43BD-864A-39A3D5B1BEC7Q41537638-0586681B-D0AF-4ECE-84B3-BFBB6308DF95Q42949588-AE78EAC0-3AB7-45C8-A6A2-65BC5BB1DFB4Q47640288-D57B9E90-69A1-48A8-9CAA-B13D611AC5E5Q48125706-F17DC503-A038-428F-A770-69153FF28466Q51282624-12302E19-1F7D-4067-AC29-4F7B8CDF743CQ55431551-123F23EE-8510-41E8-900C-2CA1330C7582Q58732719-89ED7427-9E6D-4B41-A853-184867BD686E
P2860
A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
A phase II study of amrubicin, ...... reviously treated lung cancer.
@en
A phase II study of amrubicin, ...... reviously treated lung cancer.
@nl
type
label
A phase II study of amrubicin, ...... reviously treated lung cancer.
@en
A phase II study of amrubicin, ...... reviously treated lung cancer.
@nl
prefLabel
A phase II study of amrubicin, ...... reviously treated lung cancer.
@en
A phase II study of amrubicin, ...... reviously treated lung cancer.
@nl
P2093
P1433
P1476
A phase II study of amrubicin, ...... reviously treated lung cancer.
@en
P2093
Akihiro Yoshii
Hiroaki Tsurumaki
Hironobu Iijima
Hisao Imai
Kimihiro Shimizu
Kyoichi Kaira
Masatomo Mori
Mitsuyoshi Utsugi
Naoto Fueki
Noriaki Sunaga
P304
P356
10.1016/J.LUNGCAN.2009.09.012
P577
2009-10-23T00:00:00Z